{"nctId":"NCT00102063","briefTitle":"Aripiprazole in Adolescents With Schizophrenia","startDateStruct":{"date":"2004-07"},"conditions":["Schizophrenia"],"count":302,"armGroups":[{"label":"Aripiprazole 10 mg/day Group","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Aripiprazole tablet, 10 mg"]},{"label":"Aripiprazole 30 mg/day Group","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Aripiprazole tablet, 30 mg"]},{"label":"Placebo Group","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo tablet"]}],"interventions":[{"name":"Aripiprazole tablet, 10 mg","otherNames":["OPC-14597"]},{"name":"Aripiprazole tablet, 30 mg","otherNames":["OPC-14597"]},{"name":"Placebo tablet","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Primary diagnosis of Schizophrenia 1\n\nExclusion Criteria:\n\n* Patients diagnosed with schizoaffective disorder, major depressive disorder, delirium, or bipolar disorder","healthyVolunteers":false,"sex":"ALL","minimumAge":"13 Years","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Positive and Negative Syndrome Scale (PANSS) Total Score","description":"Change from baseline to last observed post-baseline value in PANSS total score, using the last observation carried forward.\n\nThis scale consists of symptom constructs (7 positive, 7 negative, 16 general psychopathology), each to be rated on a 7-point scale of severity with 1 being absent to 7 being extreme. Minimum score is 30 which is best outcome; maximum score is 210 for worse outcome.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-26.7","spread":"1.9"},{"groupId":"OG001","value":"-28.6","spread":"0.9"},{"groupId":"OG002","value":"-21.2","spread":"1.9"}]}]}]},{"type":"SECONDARY","title":"Change in Positive and Negative Syndrome Scale (PANSS) Positive Subscale Score","description":"Change from baseline to last observed post-baseline value in PANSS positive subscale score, using the last observation carried forward.\n\nScale consists of 7 positive symptom constructs each to be rated on a 7- point scale of severity with 1 = absent to 7 = extreme. Minimum score is 7 which is best outcome; maximum score is 49 for worse outcome.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.6","spread":"0.6"},{"groupId":"OG001","value":"-8.1","spread":"0.6"},{"groupId":"OG002","value":"-5.6","spread":"0.6"}]}]}]},{"type":"SECONDARY","title":"Change in Positive and Negative Syndrome Scale (PANSS) Negative Subscale Score","description":"Change from baseline to last observed post-baseline value in PANSS Negative Subscale score, using the last observation carried forward.\n\nScale consists of 7 negative symptom constructs each to be rated on a 7- point scale of severity with 1 = absent to 7 = extreme. Minimum score is 7 which is best outcome; maximum score is 49 for worse outcome.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.9","spread":"0.6"},{"groupId":"OG001","value":"-6.6","spread":"0.6"},{"groupId":"OG002","value":"-5.4","spread":"0.6"}]}]}]},{"type":"SECONDARY","title":"Change in Clinical Global Impression (CGI) Severity Score","description":"Change from baseline to last observed post-baseline value in CGI severity score, using the last observation carried forward.\n\nScale refers to the global impression of the subject with respect to severity of the illness. The scale rates the subject's severity of illness from 0 (not rated) to 1 (least severe) to 7 (most severe).","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.2","spread":"0.1"},{"groupId":"OG001","value":"-1.3","spread":"0.1"},{"groupId":"OG002","value":"-0.9","spread":"0.1"}]}]}]},{"type":"SECONDARY","title":"Clinical Global Impression (CGI) Improvement Score","description":"Last observed post-baseline value in CGI improvement score, using the last observation carried forward.\n\nScale refers to the global impression of the subject with respect to improvement of the illness. The scale rates the subject's severity of illness from 0 (not rated) to 1 (least severe) to 7 (most severe).","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.7","spread":"0.1"},{"groupId":"OG001","value":"2.5","spread":"0.1"},{"groupId":"OG002","value":"3.1","spread":"0.1"}]}]}]},{"type":"SECONDARY","title":"Change in Children's Global Assessment Scale (CGAS) Score","description":"Change from baseline to last observed post-baseline value in CGAS score, using the last observation carried forward.\n\nScale is a 100-point scale measuring psychological, social, and school functioning for children aged 6 to 17 years. Minimum scores ranged from 1-10, representing the need for constant supervision (worse outcome) to maximum scores of 91-100, representing superior functioning (better outcome).","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14.7","spread":"1.5"},{"groupId":"OG001","value":"14.8","spread":"1.3"},{"groupId":"OG002","value":"9.8","spread":"1.3"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change in Pediatric Quality of Life Enjoyment and Satisfaction (PQLES) Questionnaire Total Score","description":"Change from baseline to last observed post-baseline value in PQLES total score, using the last observation carried forward.\n\nScale consists of 14 items pertaining to daily life activities and satisfaction, and an overall assessment item. Each item will be rated on a five-point scale (1=very poor, 2=poor, 3=fair, 4=good, 5=very good) with a minimum score of 14 (better outcome) and a maximum score of 70 (worse outcome).","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.2","spread":"0.9"},{"groupId":"OG001","value":"5.9","spread":"0.9"},{"groupId":"OG002","value":"4.5","spread":"0.9"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Patients Achieving Remission","description":"The number of subjects achieving remission. Remission was defined as a score of mild or less (â‰¤ 3) for items P1, P2, P3, N1, N4, N6, G5, and G9 in the PANSS score.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"53","spread":null},{"groupId":"OG001","value":"56","spread":null},{"groupId":"OG002","value":"35","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":100},"commonTop":["Extrapyramidal disorder","Somnolence","Headache","Insomnia","Nausea"]}}}